XRM |
The golden standard for diagnosing BC patients
Suitable as a screening method for BC
Finding mammary gland calcification
|
Not suitable for people under 40
Not suitable for people with high gland density
No more than twice a year
|
US |
Suitable screening for young women
Non‐invasive diagnostic methods
Finding mammary gland inflammation
|
Not suitable for small mass and atypical tissue
Affected by the examining doctor
Definition and Resolution are not high
|
MRI |
High sensitivity and specificity to invasive BC
Screening of high‐risk groups, such as family history of BC
Suitable for patients with breast‐conserving surgery
|
Not for everyone, such as patients with Claustrophobia and hypersensitivity to contrast
Not suitable for wide scale screening
Not suitable for BC staging
|
PET |
High sensitivity to BC recurrence and metastasis
Helpful for staging of the BC
High sensitivity to small breast tumour (>0.5 cm)
|
High cost, not recommended as routine screening
Not suitable for patients with hypersensitivity to Developer
|
CT |
Supplementary diagnostic method for BC, such as identifying BC with or without intrapulmonary metastases
|
Not the first choice for diagnosing BC
Radiation damage
Poor spatial resolution and need experienced doctor
|
SPECT |
High resolution, small field of vision
Recommended use when suspects metastasis (such as osseous metastasis)
|
Obtaining littler clinic information
Not suitable for patients with inflammatory bone lesions and bone proliferative metabolic abnormalities or variations
|